| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-05 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0001 |
| mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0002 |
| mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0003 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
| mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
| mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
0.0009 |
| mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.002 |